Diagnostic and Interventional Cardiology

Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success

FARXIGA Significantly Reduced the Risk of Cardiovascular Death or Worsening of Heart Failure in Patients with Mildly Reduced or Preserved Ejection Fraction in DELIVER Phase III Trial

August 29, 2022 — Detailed results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) ...

August 29, 2022

News | Implantable Cardioverter Defibrillator (ICD)

Medtronic Extravascular ICD meets global pivotal clinical trial’s safety and effectiveness endpoints

August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...

August 29, 2022

Amarin Corporation plc announced that new REDUCE-IT data show that VASCEPA/VAZKEPA (icosapent ethyl) significantly reduced cardiovascular (CV) events in patients with a history of smoking.

News | ESC

New REDUCE-IT Data Released at ESC Oral Presentation Session

August 29, 2022 — Amarin Corporation plc announced that new REDUCE-IT data show that VASCEPA/VAZKEPA (icosapent ethyl) ...

August 29, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

A study from the Smidt Heart Institute and Cedars-Sinai's Division of Artificial Intelligence in Medicine shows that AI was more accurate in diagnosing cardiac function than sonographers. Illustration by Getty.

News | Artificial Intelligence

Late-Breaking Heart Research: AI More Accurate Than Technicians

August 29, 2022 — In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and ...

August 29, 2022

News | Cardiovascular Education

USPSTF Issues Statin Recommendation Statement

August 29, 2022 — The US Preventive Services Task Force (USPSTF) has issued a Recommendation Statement, relating to ...

August 29, 2022

COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure, according to research presented at ESC Congress 2022.

News | Coronavirus (COVID-19)

COVID mRNA Vaccines are Safe in Patients with Heart Failure

August 26, 2022 — COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure ...

August 26, 2022

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

A new Cedars-Sinai study is the first study proven to be effective at identifying coronary artery disease patients at highest risk for sudden cardiac death. Photo by Cedars-Sinai.

News | Sudden Cardiac Arrest

Genetic Score Detects Those at Risk for Sudden Cardiac Death

August 26, 2022 — Researchers in the Smidt Heart Institute at Cedars-Sinai are one step closer to identifying patients ...

August 26, 2022

The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that the program is now available for the TCT MedTech Innovation Forum.

News | TCT

CRF and Fogarty Innovation Announce Agenda for TCT MedTech Innovation Forum

August 26, 2022 — The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that the program ...

August 26, 2022

News | PET Imaging

Late Breaking Flurpiridaz Trial Results at ASNC2022

August 25, 2022 — The results of “A Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron ...

August 25, 2022

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

Imperfect current propagation in the heart is at the root of most cardiac diseases

News | Cardiac Imaging

Measuring Currents in the Heart at Millimeter Resolution with a Diamond Quantum Sensor

August 25, 2022 — Imperfect current propagation in the heart is at the root of most cardiac diseases. Thanks to a novel ...

August 25, 2022

Independent Data Presented at the World Federation of Interventional and Therapeutic Neuroradiology 2022 Annual Meeting Highlights the Benefits of Vessel-Matching with Zoom Reperfusion Catheters

News | Stroke

Imperative Care Announces Positive New Data Underscoring the Safety and Efficacy of the Zoom Stroke Solution to Treat Distal Occlusions in Ischemic Stroke Patients

August 25, 2022 — Imperative Care, Inc. announced that new data evaluating the utility of the Zoom Stroke Solution were ...

August 25, 2022

The U.S. Food and Drug Administration (FDA) issued a statement that Medtronic, Inc. is recalling HeartWare HVAD System batteries because the batteries may experience electrical faults that cause them to unexpectedly fail.

News | Ventricular Assist Devices (VAD)

Medtronic Recalls HeartWare HVAD System Batteries for Electrical Faults That Cause Battery Failure

August 25, 2022 — The U.S. Food and Drug Administration (FDA) issued a statement that Medtronic, Inc. is recalling ...

August 25, 2022

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Dr. Jonathan Roberts is medical director of Clinical Research and Education, Interventional Cardiology for Memorial Healthcare System and program director of its Cardiology Fellowship program.

News | Heart Failure

Congestive Heart Failure Patients May Be Eligible for Treatment that Could Help Them Live Longer

August 24, 2022 — Patients diagnosed with moderate aortic stenosis and congestive heart failure may qualify to ...

August 24, 2022

News | Stroke

iHealthScreen Inc. Introduces An Automated Stroke Prediction Model, based on AI and Color Fundus Imaging

August 24, 2022 — iPredict late stroke prediction model provides a fully automated prediction score for incident stroke ...

August 24, 2022

A study simulating a population of 30 million people 65 and older found that wrist-wearable devices are more cost-effective than traditional electrocardiograms and pulse palpation for atrial fibrillation (AF) screening, and that they are associated with a reduction in stroke incidence

News | Wearables

Wrist-Worn Devices are Shown by Mass General Researchers to be Cost-Effective for Screening of Atrial Fibrillation

August 24, 2022 — Screening individuals for atrial fibrillation (AF) using wearable devices is more cost-effective than ...

August 24, 2022